US: (888) 231-0816


Fast-track your journey from R&D to commercialization

In a complex, competitive, and fast-paced market, startups in biotechnology and biopharma, and early-stage medical device companies face many challenges on their journey from R&D to commercialization. Hosted by USDM Life Sciences in collaboration with Box, this virtual event will provide valuable guidance and best practices to drive your compliance and technology strategy and roadmap.

Feb 23, 2023, 12-2 pm ET | 9-11 am PT

Session 1 | IT & Quality Strategy & Roadmap

A discussion on trends in emerging life sciences technology and compliance.

  • Emerging industry trends in quality and technology
  • IT strategy and roadmap guidance
  • Quality considerations in early-stage planning
  • Regulatory implication of the FDA’s CSA guidance
  • Live Q&A

Panelists:

  • Roger Davy, Director Customer Engagement, USDM
  • Paula Dawson, Senior Program Manager, USDM
  • Dom Glavach, Chief Security Officer and Chief Security Strategist, CyberSN
  • Matt Webb, Interim CIO, Elevar Therapeutics

Session 2 | Maintaining Cloud Compliance & Enabling Automation

How to manage your GxP cloud workloads to enable automation and create more efficient GxP business processes.

  • An integrated approach to Quality & IT
  • USDM framework for compliance to enable a continuously compliant tech stack
  • Quality orchestration through automation
  • Live Q&A

Panelists:

Session 3 | Compliant Cloud Content Management

Businesses run on content. Learn how content and documents can be managed and shared while staying secure.

  • GxP and CSA compliance for content management
  • How customers are using cloud content management to achieve efficiency and security
  • What the right technology can do to help achieve virtual audit success
  • Live Q&A

Panelists:

 

Please email usdm@usdm.com with any questions.

Register Now

Please fill out the form to register

Want to talk with our
subject matter experts?